Article
Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome.
Pediatric blood & cancer - 1 Jun 2014
Hitzler Johann K, He Wensheng, Doyle John, Cairo Mitchell, Camitta Bruce M, Chan Ka Wah, Diaz Perez Miguel A, Fraser Christopher, Gross Thomas G, Horan John T, Kennedy-Nasser Alana A, Kitko Carrie, Kurtzberg Joanne, Lehmann Leslie, O'Brien Tracey, Pulsipher Michael A, Smith Franklin O, Zhang Mei-Jie, Eapen Mary, Carpenter Paul A
Abstract excerpt
We report on 27 patients with Down syndrome (DS) and acute lymphoblastic leukemia (ALL) who received allogeneic hematopoietic cell transplantation (HCT) between 2000 and 2009. Seventy-eight percent of patients received myeloablative conditioning and 52% underwent transplantation in second remission. Disease-free survival (DFS) was 24% at a median of 3 years. Post-transplant leukemic relapse was more frequent than...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
